- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/426 - 1,3-Thiazoles
Patent holdings for IPC class A61K 31/426
Total number of patents in this class: 3129
10-year publication summary
|
201
|
203
|
203
|
223
|
242
|
224
|
243
|
247
|
196
|
63
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1145 |
42 |
| The Regents of the University of California | 18943 |
41 |
| Genfit | 257 |
41 |
| Bristol-myers Squibb Company | 5080 |
32 |
| Romark Laboratories L.C. | 60 |
31 |
| Actelion Pharmaceuticals Ltd | 576 |
30 |
| EyePoint Pharmaceuticals, Inc. | 100 |
30 |
| Takeda Pharmaceutical Company Limited | 2961 |
25 |
| University of Florida Research Foundation, Inc. | 3883 |
24 |
| Purdue Research Foundation | 3277 |
23 |
| Shionogi & Co., Ltd. | 914 |
22 |
| Dompé Farmaceutici S.p.A. | 239 |
21 |
| Centre National de La Recherche Scientifique | 9632 |
20 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
20 |
| Toray Industries, Inc. | 6652 |
19 |
| Duke University | 2872 |
19 |
| Teijin Pharma Limited | 258 |
19 |
| vTv Therapeutics LLC | 159 |
19 |
| Vanda Pharmaceuticals, Inc. | 336 |
18 |
| Janssen Pharmaceutica N.V. | 3839 |
17 |
| Other owners | 2616 |